Y-Biologics, Inc

Corporate Details

ISIN(s):

N/A

LEI:

Country:

South Korea

Address:

대전광역시 유성구 테크로 4로 17, 비715호, 대전광역시

Website:

https://ybiologics.com/en/

Sector:

Mining and quarrying

Industry:

Mining of non-ferrous metal ores

Description

Y-Biologics, Inc. is a biopharmaceutical company established in 2007, specializing in the research and development of novel antibody therapeutics. The company's core R&D is driven by its proprietary platform technologies. These include Ymax®-ABL, a fully human antibody library that serves as the foundation for its discovery process, and ALiCE (Antibody-Like Cell Engager), a globally patented bispecific T-cell engager platform. The ALiCE technology creates Y-shaped molecules designed to simultaneously bind to cancer cells and T-cells, thereby activating the T-cells to directly eliminate tumors. Y-Biologics' pipeline features immuno-oncology candidates such as YBL-006, an anti-PD-1 antibody, and YBL-013, an ALiCE-based therapeutic. The company's business model involves both in-house development and open innovation through joint research and technology licensing partnerships with global pharmaceutical firms.